Jack Henningfield

Jack Henningfield is vice president of research, health policy and abuse liability at Pinney Associates and adjunct professor of behavioral biology in the department of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine, where he has been on the faculty since 1978. Henningfield is a past president of the Society for Research on Nicotine and Tobacco.

He served on the U.S. Food and Drug Administration’s (FDA) first Tobacco Products Scientific Advisory Committee and the World Health Organization’s first Study Group on Tobacco Product Regulation and its predecessor, from 2000 to 2014. Before Pinney Associates, Henningfield headed clinical pharmacology and the Abuse Potential Assessment Laboratory of the National Institute on Drug Abuse, where he advised FDA on controlled substance issues.

He was an editor of the 1988 surgeon general’s report on nicotine addiction, as well as many other reports, including the 50th anniversary 2014 surgeon general’s report. Henningfield has researched the neuropharmacology of alcohol, cannabis, opioids, nicotine, sedatives and stimulants, as well as many medicines for treating pain and psychiatric disorders, resulting in more than 400 scientific articles, books and monographs.

At Pinney Associates his focus is the assessment and regulation of drugs and drug-delivery systems to reduce their abuse and harmful effects.